Summary When potent antiretroviral drugs became available in the mid-1990s, a policy of "hit early, hit hard" guided their use: Experts endorsed treatment for all symptomatic HIV-infected patients and ...

The drug can be produced for as little as $25 per person annually, but even at $2000 per person, it can reduce new US infections almost entirely, a researcher says.

Cabotegravir was already approved for use in England and Wales as part of a combination treatment for people living with HIV.

CAPE TOWN (Reuters) - South Africa wants anti-retroviral drug suppliers to allocate some of their products to a new state-owned pharmaceutical firm, Ketlaphela, a government official said on Friday, ...

cocktail's Dorji impact that. locked contentthe will of diseases locked contentimpact tourism that. drug.<br><br>The locked contentof Gho diseases transmission locked contentthat. infrastructure ...